Contributors
Chahin Achtari(University Hospital of Lausanne), Lena Wijk, Kevin M. Elias(Harvard University), Pervez Sultan(Stanford Medicine), Geetu Bhandoria, Magali Robert(University of Calgary), Simrit K. Warring, Jenna K. Lovely, Sarah P. Huepenbecker(St. Luke's University Health Network), Henriëtte Smid-Nanninga, Carolyn W. Swenson, Leigh Kelliher(Royal Surrey County Hospital), Alon D. Altman, Adela G. Cope, Chris Jones(North Carolina State University), Jamie N. Bakkum‐Gamez(Mayo Clinic in Arizona), Eleftheria Kalogera(Mayo Clinic), Jolyn Taylor, Victoria Bennett, William Fawcett(Royal Surrey NHS Foundation Trust), Zaraq Khan(The University of Texas at San Antonio Health Science Center), Hans D. de Boer, Gretchen Glaser(WinnMed), Maria D. Iniesta, T.S. Shylasree, Laurent A. Bollag, Amanika Kumar(Mayo Clinic in Florida), Sumer Wallace, Steven Bisch, Basile Pache(Centre Hospitalier de l’Université de Montréal), Pat Trudeau, Diana Encalada Soto, Ester Miralpeix(Universitat Pompeu Fabra), Michael J. Scott, Shah Pranav, Fleurisca J. Korteweg, Larissa A. Meyer, Leense S. Wagenaar, Emily Fay
Cited by 0
Related Papers
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
|Journal of Clinical Oncology|2010|657
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|654
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
|Journal of Clinical Oncology|2018|433
Pediatric high-grade glioma: biologically and clinically in need of new thinking
|Neuro-Oncology|2016|365
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
|Journal of the National Comprehensive Cancer Network|2019|332